fulvestrant has been researched along with ascorbic acid in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Bershteĭn, LM; Kovalenko, IG; Poroshina, TE; Tsyrlina, EV; Vasil'ev, DA | 1 |
Chae, YS; Jeong, JH; Jung, JH; Lee, DH; Lee, IH; Lee, J; Lee, SJ; Park, HY | 1 |
1 review(s) available for fulvestrant and ascorbic acid
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
2 other study(ies) available for fulvestrant and ascorbic acid
Article | Year |
---|---|
[Switching off the estrogen effect and approaches to its correction].
Topics: Acetylcysteine; Aging; Animals; Antioxidants; Ascorbic Acid; Carnosine; Cell Cycle; DNA Damage; Estradiol; Estrogen Receptor Modulators; Estrogens; Ethanol; Female; Fulvestrant; Gamma Rays; Melatonin; Organ Size; Ovariectomy; Physical Conditioning, Animal; Rats; Smoking; Swimming; Uterus; Vitamin D | 2003 |
Effect of High-dose Vitamin C Combined With Anti-cancer Treatment on Breast Cancer Cells.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Ascorbic Acid; Breast Neoplasms; Cell Line, Tumor; Cell Survival; Drug Screening Assays, Antitumor; Drug Synergism; Female; Fulvestrant; Furans; Humans; Ketones; MCF-7 Cells; Tamoxifen; Trastuzumab | 2019 |